AIDS Healthcare Foundation (AHF) reported on Wednesday that the US will have 3m vaccine doses per day available by April in the fight against the COVID-19 variants.
In conjunction, the company's Ryan White HIV Clinics will offer its sites to administer the COVID-19 vaccines.
On Tuesday, AstraZeneca, Johnson & Johnson, Moderna, Novavax and Pfizer have reportedly testified at the US House of Representatives Energy and Commerce Subcommittee on Oversight and Investigations. Each company presented the scaled-up production numbers for the vaccines that have been approved by the US Food and Drug Administration (FDA).
AHF is the largest global AIDS organization and currently provides medical care and/or services to over 1.5m people in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region as well as Eastern Europe.
DATROWAY receives US priority review for first-line metastatic triple negative breast cancer
Lupin launches Dasatinib tablets in US market
Natera submits Signatera CDx PMA to FDA for bladder cancer use
Pharming receives FDA complete response letter for paediatric Joenja application
Trace Biosciences' IND application for nerve-specific imaging agent approved by FDA
Frontage expands early phase clinical research capabilities across US and China
MicuRx Pharmaceuticals' IND application for MRX-5 cleared by FDA
FDA approves Tenpoint Therapeutics' YUVEZZI as first dual-agent eye drop for presbyopia
Summit Therapeutics' BLA for ivonescimab in EGFR-mutated NSCLC accepted by FDA
WuXi Biologics collaborates with Sinorda Biomedicine for antibody development
Biogen's litifilimab receives FDA Breakthrough Therapy Designation for CLE
Glaukos receives FDA approval for repeat administration of iDose TR
Guerbet's contrast agent Elucirem approved by European Commission in children from birth
Spine Innovation's LOGIC Titanium Implant System receives US FDA 510(k) market approval